Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings

Fig. 2

One-way sensitivity analysis of key input parameters on incremental cost-effectiveness ratio of inhaled oxytocin introduction in Bangladesh. a Incremental cost per maternal life year saved. b Incremental cost per maternal and child life year saved. c Incremental cost per maternal life year saved when including only ongoing costs. d Incremental cost per maternal and child life year saved when including only ongoing costs. Black bars represent deterministic sensitivity analyses; grey bars represent scenario analyses; white bars represent structural uncertainty analyses. Solid vertical line represents base case; dashed vertical lines represent cost-effectiveness thresholds of 25%, 50% and 1 GDP per capita. GDP, gross domestic product; ICER, incremental cost-effectiveness ratio; IHO, inhaled oxytocin; PPH, postpartum haemorrhage

Back to article page